🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluation of efficacy of Intravitreal Injection of Bevacizumab in patients...
Status
Withdrawn
Location
Asociacion para Evitar la Ceguera en Mexico
Start Date
2006-09
Trial ID
NCT00406380
Treatments Being Tested
200 eyes with each subtype of neovascular age-related macular degeneration ...
Status
Completed
Location
Multiple Locations
Start Date
2009-08
Trial ID
NCT01027468
Treatments Being Tested
The purpose of this study is to provide access to intravitreal injection of...
Status
No Longer Available
Location
Childrens Hospital Los Angeles
Start Date
TBD
Trial ID
NCT00870636
Treatments Being Tested
There is an unmet need for patients with intermediate stage hepatocellular ...
Status
Terminated
Location
Yale New Haven Hospital
Start Date
2023-06-07
Trial ID
NCT05776875
Treatments Being Tested
The authors investigated the consecutive change of retinal vessel's diamete...
Status
Completed
Location
Dong Ho Park
Start Date
2012-04
Trial ID
NCT02215109
Although multiple studies have suggested that treatment with ranibizumab is...
Status
Completed
Location
Retina Associates
Start Date
2012-08
Trial ID
NCT01627249
This was the cross-sectional study to assess the period prevalence of IOI i...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-07-15
Trial ID
NCT05146687
Treatments Being Tested
The research group has developed new ocular drug delivery technology based ...
Status
Unknown
Location
College of Medicine, King Saud University
Start Date
2012-03
Trial ID
NCT01523314
Treatments Being Tested
Choroidal neovascularization is a leading cause of visual loss in people ol...
Status
Terminated
Location
Asociacion para Evitar la Ceguera en Mexico
Start Date
2006-05
Trial ID
NCT00406744
Treatments Being Tested
In this cross-sectional study of patients with wet AMD who received ≥1 anti...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-07-15
Trial ID
NCT05110209
Treatments Being Tested